presented by boris winterhoff at 2014 asco annual meeting
DESCRIPTION
Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal Molecular Subtype of Ovarian Cancer. Presented By Boris Winterhoff at 2014 ASCO Annual Meeting. Disclosure. Presented By Boris Winterhoff at 2014 ASCO Annual Meeting. Slide 3. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/1.jpg)
Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal Molecular Subtype of Ovarian Cancer
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 2: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/2.jpg)
Disclosure
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 3: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/3.jpg)
Slide 3
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 4: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/4.jpg)
ICON7/AGO-OVAR 11
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 5: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/5.jpg)
ICON7/AGO-OVAR 11 <br />PFS and OS
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 6: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/6.jpg)
ICON7/AGO-OVAR 11 <br />PFS and OS<br />High risk group suboptimal stage III and stage IV
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 7: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/7.jpg)
Molecular Classification of HGS Ovarian Cancer
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 8: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/8.jpg)
Slide 8
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 9: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/9.jpg)
Slide 9
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 10: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/10.jpg)
Slide 10
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 11: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/11.jpg)
Slide 11
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 12: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/12.jpg)
Slide 12
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 13: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/13.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Overall (n=359)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 14: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/14.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />High risk for progression (n=119)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 15: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/15.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Proliferative Subtype (n=96)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 16: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/16.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Mesenchymal Subtype (n=68)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 17: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/17.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Differentiated Subtype (n=73)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 18: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/18.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Immunoreactive Subtype (n=122)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 19: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/19.jpg)
Slide 19
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 20: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/20.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Proliferative Subtype HGS (n=63)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 21: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/21.jpg)
PFS and OS AGO OVAR 11/ICON7 DASL Study Cohort<br />Mesenchymal Subtype HGS (n=43)
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 22: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/22.jpg)
Summary
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 23: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/23.jpg)
Conclusion
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 24: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/24.jpg)
Acknowledgements
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
![Page 25: Presented By Boris Winterhoff at 2014 ASCO Annual Meeting](https://reader036.vdocument.in/reader036/viewer/2022062305/56816252550346895dd29a5c/html5/thumbnails/25.jpg)
Summary
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting